Head-to-head · WeighScore
Eclipse Medical Wellness vs June Health
The verdict
Eclipse Medical Wellness takes it — 63.2/100 to 63/100, but only just.
Eclipse Medical Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eclipse Medical Wellness is a Colorado-only, clinician-led telehealth weight-loss program. June Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Eclipse Medical Wellness | June Health |
|---|---|---|
| WeighScore | 63.2/100 | 63/100 |
| Grade | C | C |
| Scorecard rank | #256 | #261 |
| Semaglutide | Not disclosed | $179/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $179/mo (starting dose, compounded) |
| Coverage | 1 state | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #256 · C
Strengths
- Clinician-led care with baseline and quarterly lab monitoring included
- Prescribes FDA-approved brand GLP-1 (Wegovy, Zepbound); compounded options also available
- Transparent care-plan pricing ($749 3-month starter, ~$149/mo ongoing) with nutrition support
- Includes a prior-authorization attempt plus dose-adjustment and side-effect monitoring
Where it loses points
- Colorado residents only
- Care-plan fees are separate from medication — you pay for the drug at your pharmacy
- Prescription is not guaranteed (depends on clinical evaluation)
- Small practice; no Terms or Privacy pages found on the site
Graded #261 · C
Strengths
- Offers both injectable and oral compounded semaglutide and tirzepatide
- Semaglutide starts at $179/mo (injectable) or $187/mo (tablets) — tirzepatide from $179/mo (injectable)
- Full per-dose price list published on-site with no signup required to view it
- Provider consult ('licensed clinician evaluation') is bundled into the displayed price
- Free discreet shipping advertised with 2-3 day delivery
Where it loses points
- No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
- No LegitScript seal or other pharmacy-verification badge found anywhere on the site
- Legal entity, prescribing medical group, and compounding pharmacy partner are not named
- Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
- Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.